Backed by $52 million in Series A financing led by 8VC and named after a feat of engineering in ancient Rome, Appia Bio jumped into the cell therapy fray this morning with a promising scalable technology platform.
Other articles
June 28, 2024
Freeflow Ventures Raises $90M In Funding For Early Stage Deep Tech Investments
Freeflow Ventures, announced today that it raised $50M in new funds through its…